Genomic Health, Inc.
GHDX
GHDX was delisted on the 7th of November, 2019.
134 hedge funds and large institutions have $1.01B invested in Genomic Health, Inc. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 7 closing their positions.
171% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 7
100% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 29
8% more funds holding
Funds holding: 124 → 134 (+10)
0% more capital invested
Capital invested by funds: $1.01B → $1.01B (+$809K)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$13.3M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$2.67M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.62M |
| 4 |
Morgan Stanley
New York
|
+$2.57M |
| 5 |
Goldman Sachs
New York
|
+$2.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$8.86M |
| 2 |
BlackRock
New York
|
-$7.91M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.6M |
| 4 |
SCA
Secor Capital Advisors
New York
|
-$1.51M |
| 5 |
Two Sigma Investments
New York
|
-$1.24M |
GHDX Hedge Fund Activity: Q3 2017 in Review
134 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q3 2017, worth a combined $1.01B — up 0.08% from $1.01B a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new GHDX positions and 7 closed out — a net gain of 12 holders — while 58 added to existing stakes and 29 trimmed.
The largest buyer was Millennium Management, adding an estimated $13.3M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $8.86M.
- 134 institutional investors held Genomic Health, Inc. (GHDX) as of Q3 2017, up from 124 in Q2 2017.
- Funds reported $1.01B of Genomic Health, Inc. stock for Q3 2017, up 0.08% quarter-over-quarter.
- 19 funds opened new Genomic Health, Inc. positions in Q3 2017 and 7 closed out, a net change of +12 holders.
- The largest Genomic Health, Inc. buyer in Q3 2017 was Millennium Management, an estimated $13.3M added.
- The largest Genomic Health, Inc. seller in Q3 2017 was Columbia Wanger Asset Management, an estimated $8.86M sold.
Based on aggregated 13F filings for Q3 2017.